Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
Intercept hit hard as FDA issues Ocaliva safety notice
The PBC treatment has been linked to 19 deaths and 11 cases of liver damage
Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio
Germany and the UK will be the first to receive the skin cancer treatment
Novartis gets EU nod for leukaemia drug Rydapt
The FLT3 inhibitor adds to its US approval in AML
Alnylam takes off on APOLLO trial results
Provides first late-stage evidence on the biotech's gene-silencing platform
Articles
-
AI’s potential in the pharma life cycleAt a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take
-
And breathe……or, why there is no ‘fast track’ to communications excellence
-
HumanisationThe key to delivering communications excellence
-
Attracting doctors to low-demand specialtiesA role for industry?
-
Signal strengthCommunications that connect
Pharmaceutical Market Europe - September 2017
From Brexit to European elections to strategic planning, change figures highly in this month's PME
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Dominic Tyer
Have your say...
Subscribe
Dr Paula Salmikangas joins NDA Group
Moves to the regulatory affairs consultancy from the Finnish Medicines Agency
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
FDA approves Medtronic's tablet-controlled pain device
The Intellis system can be programmed via a Samsung's Galaxy S2
Featured jobs
- Director of Scientific and Editorial Services
-
Great salary and benefits - Circa 100K
- Junior - Mid Level Medical Copywriter, Healthcare Advertising Ag...
-
£30-35, 000 according to skills and experience
-
Programme Director
-
Salary TBC
-
Account Director
-
Salary TBC
Subscribe to our email news alerts
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- AI’s potential in the pharma life cycle
- At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...
- OUTiCO Case Study - Product Launch
- POSITIVE FORMULARY SUCCESS WITHIN 8 MONTHS!...
- An insight into Multi-Channel Account Management
- At OUTiCO we often talk about moving away from traditional methods, embracing change, and offering an exceptional outsourcing service, but what does that mean day to day?...
Quick links
Infographics
